In an open clinical trial, curcumin was administered in an oral dose of 375 mg three times daily for 12 weeks to 53 patients with chronic anterior uveitis. [8] Twentyone patients dropped out of ...

An evaluation for a pilot that saw patients redirected from secondary care to be managed by independent prescribing (IP) optometrists in the community shows a reduction in the weekly workload of ...

Cortrophin Gel is a prescription medicine that is injected subcutaneously or intramuscularly indicated for severe acute and ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growthSYFOVRE® (pegcetacoplan injection) full year 2024 net ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified Cortrophin® ...

Its use in non-anterior non-infectious uveitis is controversial, with evidence generally not supporting its effectiveness in these conditions. However, the role of secukinumab in anterior ...

Cataract surgery in small hyperopic eyes can be challenging due to the constraints of working in a significantly smaller ...

Among the 255 children recruited, anterior uveitis was predominant (76.9%) and 65% of cases were bilateral. Peak incidence was at 11–15 years. Children resident in deprived areas and those from ...